Cargando…

Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case

BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugie, Akira, Yamada, Makoto, Yokoyama, Kunio, Miyake, Tomoaki, Ito, Yutaka, Tanaka, Hidekazu, Nomura, Yukiya, Fujita, Masutsugu, Nakatani, Toshio, Kawanishi, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Neurological Surgeons 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394676/
https://www.ncbi.nlm.nih.gov/pubmed/36046799
http://dx.doi.org/10.3171/CASE20175
_version_ 1784771530977181696
author Sugie, Akira
Yamada, Makoto
Yokoyama, Kunio
Miyake, Tomoaki
Ito, Yutaka
Tanaka, Hidekazu
Nomura, Yukiya
Fujita, Masutsugu
Nakatani, Toshio
Kawanishi, Masahiro
author_facet Sugie, Akira
Yamada, Makoto
Yokoyama, Kunio
Miyake, Tomoaki
Ito, Yutaka
Tanaka, Hidekazu
Nomura, Yukiya
Fujita, Masutsugu
Nakatani, Toshio
Kawanishi, Masahiro
author_sort Sugie, Akira
collection PubMed
description BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological symptoms that suggest the involvement of initially unaffected vascular territories after intravenous thrombolysis (IVT). The authors reviewed the cases of ERIS that occurred within 24 hours after treatment with IVT. OBSERVATIONS: A 75-year-old woman with occlusion in the M2 segment of the left middle cerebral artery (MCA) was treated with IV t-PA. However, 360 minutes later, the patient presented with occlusion in the M1 distal segment of the contralateral side, the right MCA, which was recanalized by endovascular treatment. Her modified Rankin Scale score was 4; however, aphasia was not observed. She was transferred to a rehabilitation hospital after 3 months. LESSONS: ERIS is an extremely rare but catastrophic event. The underlying mechanism of ERIS most likely involves the disintegration and subsequent scattering of a preexisting intracardiac thrombus. Hence, caution must be used when managing not only hemorrhagic complications but also ischemic complications after IV t-PA. Endovascular management may be the only effective treatment for this type of large vessel occlusion.
format Online
Article
Text
id pubmed-9394676
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association of Neurological Surgeons
record_format MEDLINE/PubMed
spelling pubmed-93946762022-08-30 Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case Sugie, Akira Yamada, Makoto Yokoyama, Kunio Miyake, Tomoaki Ito, Yutaka Tanaka, Hidekazu Nomura, Yukiya Fujita, Masutsugu Nakatani, Toshio Kawanishi, Masahiro J Neurosurg Case Lessons Case Report BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological symptoms that suggest the involvement of initially unaffected vascular territories after intravenous thrombolysis (IVT). The authors reviewed the cases of ERIS that occurred within 24 hours after treatment with IVT. OBSERVATIONS: A 75-year-old woman with occlusion in the M2 segment of the left middle cerebral artery (MCA) was treated with IV t-PA. However, 360 minutes later, the patient presented with occlusion in the M1 distal segment of the contralateral side, the right MCA, which was recanalized by endovascular treatment. Her modified Rankin Scale score was 4; however, aphasia was not observed. She was transferred to a rehabilitation hospital after 3 months. LESSONS: ERIS is an extremely rare but catastrophic event. The underlying mechanism of ERIS most likely involves the disintegration and subsequent scattering of a preexisting intracardiac thrombus. Hence, caution must be used when managing not only hemorrhagic complications but also ischemic complications after IV t-PA. Endovascular management may be the only effective treatment for this type of large vessel occlusion. American Association of Neurological Surgeons 2021-04-12 /pmc/articles/PMC9394676/ /pubmed/36046799 http://dx.doi.org/10.3171/CASE20175 Text en © 2021 The authors https://creativecommons.org/licenses/by-nc-nd/4.0/CC BY-NC-ND 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Case Report
Sugie, Akira
Yamada, Makoto
Yokoyama, Kunio
Miyake, Tomoaki
Ito, Yutaka
Tanaka, Hidekazu
Nomura, Yukiya
Fujita, Masutsugu
Nakatani, Toshio
Kawanishi, Masahiro
Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
title Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
title_full Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
title_fullStr Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
title_full_unstemmed Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
title_short Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
title_sort vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394676/
https://www.ncbi.nlm.nih.gov/pubmed/36046799
http://dx.doi.org/10.3171/CASE20175
work_keys_str_mv AT sugieakira vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT yamadamakoto vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT yokoyamakunio vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT miyaketomoaki vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT itoyutaka vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT tanakahidekazu vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT nomurayukiya vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT fujitamasutsugu vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT nakatanitoshio vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase
AT kawanishimasahiro vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase